Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: A meta-analysis
- 8 January 2007
- Vol. 25 (4) , 709-718
- https://doi.org/10.1016/j.vaccine.2006.08.015
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Measuring inconsistency in meta-analysesBMJ, 2003
- Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection responseVaccine, 2003
- Granulocyte-Macrophage Colony-Stimulating Factor as an Adjuvant to Hepatitis B Vaccination in Maintenance Hemodialysis PatientsAmerican Journal of Nephrology, 2000
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitroInternational Journal of Immunopharmacology, 1991
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984